CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising government focus towards preventive healthcare
4.1.2. Growing importance of healthy life expectancy
4.1.3. Increasing research activities
4.1.4. Increasing burden of chronic diseases
4.2. Market Restraints & Challenges
4.2.1. Differences in the cost of test kits offered by different companies
4.2.2. Limited reimbursement
4.3. Market Opportunities
4.3.1. Expansion in emerging economies
4.3.2. Potential applications of cellular health screening in precision and personalised
medicine
CHAPTER 5. GLOBAL CELLULAR HEALTH SCREENING MARKET – BY
SAMPLE TYPE
5.1. Introduction
5.2. Blood Samples
5.3. Other Samples
CHAPTER 6. GLOBAL CELLULAR HEALTH SCREENING MARKET – BY TYPE
6.1. Introduction
6.2. Single test panels
6.2.1. Telomere tests
6.2.2. Heavy metals tests
6.2.3. Inflammation tests
6.2.4. Oxidative stress tests
6.3. Multi-test panels
CHAPTER 7. GLOBAL CELLULAR HEALTH SCREENING MARKET – BY
SAMPLE COLLECTION SITE
7.1. Introduction
7.2. In-office sample collection
7.3. At-home sample collection
7.4. Other sites
CHAPTER 8. GLOBAL CELLULAR HEALTH SCREENING MARKET - BY
GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL CELLULAR HEALTH SCREENING MARKET - COMPANY
PROFILES
9.1. Cell Science Systems
9.2. Quest Diagnostics Incorporated.
9.3. Lab corps Holdings.
9.4. Titanovo, Inc.
9.5. Zimetry LLC.
9.6. Immundiagnostik AG.
9.7. Segterra, Inc.
9.8. Genova Diagnostics.
9.9. Cleveland Heart Lab, Inc.
9.10. Enzo Clinical Labs - Farmingdale, NY.
9.11. Spectra Cell Laboratories, Inc.
9.12. Bio-Reference Laboratories, Inc.
9.13. Valley Agriculture Software
9.14. Life Length.
CHAPTER 10. GLOBAL CELLULAR HEALTH SCREENING MARKET -
COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
